Keeping you up to date on your investment
Follow the heartbeat of our mission as we strive to transform the lives of heart failure patients. Join our journey to redefine the landscape of cardiac health and help create a brighter future for patients worldwide.
Share price chart
Presentations & Webinars
SEC Filings
Date
Announcement
Download
January 2, 2025
Form 4 - Statement of changes in beneficial ownership of securities
December 4, 2024
SC 13G
November 26, 2024
Form 4 - Statement of changes in beneficial ownership of securities
November 26, 2024
Form 3 - Initial statement of beneficial ownership of securities
November 21, 2024
10-12G/A Registration of securities [Sect 12(g)] - amendment
ASX Financial Update
Date
Announcement
Download
January 19, 2025
WiSE accepted into new TCET reimbursement pathway of CMS
January 19, 2025
EBR completes FDA PAI and update guidance on FDA approval timing
January 7, 2025
Notification of cessation of securities - EBR
January 6, 2025
Notification regarding unquoted securities - EBR
January 5, 2025
FDA Pre-Approval Inspection Update
News
Corporate governance
The EBR Board of Directors is responsible to shareholders for the overall governance and performance of the company.
The roles and responsibilities of the Board of Directors, Board Committees, management and operating subsidiaries have been established through Board-approved charters and formal delegations of authority.
The Board and Committee Charters and the Delegations of Authority provide the basis for the good governance of the company and operate in conjunction with the Constitution of the company, the Corporations Act and other relevant laws.